Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03497117 · ClinicalTrials.gov registry record · Early Phase 1
19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation
A Early Phase 1 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT03497117 is a Early Phase 1 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 5 participants.
The verdict
NCT03497117, a Early Phase 1 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to use perfluorinated gas imaging to highlight regions of functional variation within the lungs of participants with cystic fibrosis (CF), and to correlate this with changes in spirometry, lung clearance index, and quality of life of CF subjects undergoing treatment for a pulmonary exacerbation.
Interventions
- DEVICE Lung Clearance Index
- DRUG MRI with PFP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-08-25 |
| Est. Completion | 2019-09-13 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03497117
The ClinicalTrials.gov registry entry for NCT03497117 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lung Clearance Index is the first listed.
NCT03497117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03497117 about?
NCT03497117 is a clinical study titled "19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation". The purpose of this study is to use perfluorinated gas imaging to highlight regions of functional variation within the lungs of participants with cystic fibrosis (CF), and to correlate this with changes in spirometry, lung clearance index, and quality of life of CF subjects undergoing treatment for ...
What is the current status of trial NCT03497117?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2015-08-25. Estimated completion is 2019-09-13.
What interventions are being tested in trial NCT03497117?
The interventions under investigation include: Lung Clearance Index (DEVICE), MRI with PFP (DRUG).
Who is sponsoring clinical trial NCT03497117?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.